Lab News
Grail to showcase liquid biopsy method at ASCO
May 13, 2019 -- Grail announced on May 13 that its blood test for detecting multiple cancers has breakthrough device status with the U.S. Food and Drug Administration, that it has selected a next-generation sequencing method for the assay, and that it will report data at the upcoming American Society of Clinical Oncology (ASCO) annual meeting. Read More
Connect
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets